Transthoracic Ultrasound Evaluation of Pulmonary Changes in COVID-19 Patients During Treatment Using Modified Protocols

doi:10.37015/AUDT.2020.200020

Abstract

Abstract:

Objective: To investigate the feasibility of evaluating imaging changes pre-and post-treatment in Corona Virus Disease 2019 (COVID-19) patients by transthoracic pulmonary ultrasound.
Methods: A total of 8 patients diagnosed with severe or critical COVID-19 pneumonia were recruited, and then ultrasound scanning was performed to evaluate the pulmonary imaging changes pre- and post-treatment based on a modified ultrasonic Buda protocol. The correlation between chest high resolution computed tomography (HRCT) Warrick scoring and ultrasonic results was analyzed.
Results: The main manifestations of ultrasonic imaging in severe or critical COVID-19 patients were: (1) pleural thickening (8/8), blurry or irregular fragmentation (6/8), and discontinuous fragmentation (4/8); (2) pulmonary lesions: B-line sign (2/8), partial or complete fusion of B-line (white lung) (8/8), and pulmonary or subpleural small consolidation (C-line sign) in severe cases (3/8); and (3) rarely, pleural effusion or pulmonary gas cyst (1/8). The imaging results, which were evaluated followed by a modified Buda transthoracic pulmonary ultrasound protocol, were highly correlated with HRCT Warrick scoring (r = 0.715, P < 0.05). Meanwhile, both ultrasonic and HRCT imaging results were significantly improved with progressive COVID-19 treatment (P < 0.05).
Conclusion: The ultrasonic pulmonary imaging of COVID-19 patients manifested several characteristics. The modified Buda transthoracic pulmonary ultrasound protocol could be an alternative method to evaluate the pulmonary lesions in COVID-19 patients.

Key words: COVID-19; Ultrasound; Lung; Pulmonary edema; High resolution computed tomography

Guorong Lyu, MD, Ying Zhang, MD, Guoliang Tan, MD. Transthoracic Ultrasound Evaluation of Pulmonary Changes in COVID-19 Patients During Treatment Using Modified Protocols. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(2): 79-83.

References

[1]	The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese Journal of Epidemiology 2020; 41:145-151.
[1]	[In Chinese]
[2]	National Health Commission of the People's Republic of China. COVID-19's diagnosis and treatment Plan (sixth Edition). 2020; Available from:http://www.nhc.gov.cn/yzygj/s7652m/202002/54e1ad5c2aac45c19eb541799bf637e9.shtml
[3]	Buda N, Piskunowicz M, Porzezińska M, Kosiak W, Zdrojewski Z. Lung ultrasonography in the evaluation of interstitial lung disease in systemic connective tissue diseases: criteria and severity of pulmonary fibrosis - analysis of 52 patients. Ultraschall Med 2016; 37:379-85.
[4]	Mojoli F, Bouhemad B, Mongodi S, Lichtenstein D. Lung Ultrasound for Critically Ill Patients. Am J Respir Crit Care Med 2019; 199:701-714.
[5]	Lichtenstein DA, Malbrain MLNG. Lung ultrasound in the critically ill (LUCI): A translational discipline. Anaesthesiol Intensive Ther 2017; 49:430-436.
[6]	Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P, et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012; 142:965-972.
[7]	Alzahrani SA, Al-Salamah MA, Al-Madani WH, Elbarbary MA. Systematic review and meta-analysis for the use of ultrasound versus radiology in diagnosing of pneumonia. Crit Ultrasound J 2017; 9:6.
[8]	Mongodi S, Via G, Girard M, Rouquette I, Misset B, Braschi A, Mojoli F, Bouhemad B. Lung Ultrasound for Early Diagnosis of Ventilator-Associated Pneumonia. Chest 2016; 149:969-80.
[9]	Ho MC, Ker CR, Hsu JH, Wu JR, Dai ZK, Chen IC. Usefulness of lung ultrasound in the diagnosis of community-acquired pneumonia in children. Pediatr Neonatol 2015; 56:40-5.
[10]	Testa A, Soldati G, Copetti R, Giannuzzi R, Portale G, Gentiloni-Silveri N. Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound. Crit Care 2012; 16:R30.
[11]	Tsai NW, Ngai CW, Mok KL, Tsung JW. Lung ultrasound imaging in avian influenza A (H7N9) respiratory failure. Crit Ultrasound J 2014; 6:6.
[12]	Lissaman C, Kanjanauptom P, Ong C, Tessaro M, Long E, O'Brien A. Prospective observational study of point-of-care ultrasound for diagnosing pneumonia. Arch Dis Child 2019; 104:12-18.
[13]	Tsung JW, Kessler DO, Shah VP. Prospective application of clinician-performed lung ultrasonography during the 2009 H1N1 influenza a pandemic: distinguishing viral from bacterial pneumonia. Crit Ultrasound J 2012; 4:16.
[14]	Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8:420-422.
[15]	Zeng LQ, Lv GR, lian XH, Zhu ZX, Chen YJ, Xu ZR, et al. Study on the correlation between B Line in ultrasound and severity of pulmonary edema. Chinese Journal of Ultrasound in Medicine 2019; 35:272-274. [In Chinese]. Available from: http://www.cqvip.com/QK/95105X/201903/7001647781.html
[16]	Zeng LQ, LV GR, Li YY, Chen YJ, Li BY. In vitro experimental study for the formation mechanism of B line in lung ultrasound. Chinese Journal of Ultrasound in Medicine 2019; 35:560-562. [In Chinese]. Available from: http://www.cqvip.com/QK/95105X/201906/7002222377.html.